Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome
- PMID: 15782307
- DOI: 10.1007/s00467-004-1805-5
Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome
Abstract
Matrix metalloproteinases (MMPs) play an important regulatory role in many biological and pathological processes and their specific role in Alport syndrome (AS) is not yet clearly defined. In this study, the naturally occurring canine X-linked AS was used to demonstrate a potential role for MMP-3 and MMP-7 in Alport renal pathogenesis. Recently, we demonstrated that the expression of MMP-2, MMP-9 and MMP-14 was upregulated in the renal cortex of dogs with a spontaneous form of XLAS. In the present study, we examined necropsy samples of renal cortex from normal and XLAS dogs for MMP-3 and MMP-7 as they have the potential to activate MMP-2 and MMP-9. Immunohistochemical analysis showed strong immunostaining for both MMP-3 and MMP-7 in the interstitial space of XLAS kidneys, while virtually no immunostaining was observed in similar fields from normal dogs. RT-PCR and casein zymography confirmed that both mRNA transcripts and activities of MMP-3 and MMP-7 are elevated in XLAS kidneys. The induction of these MMPs likely contributes to tissue destruction associated with the fibrogenic process, while augmenting the activation of MMP-2 and MMP-9 by MMP-3 and MMP-7 in XLAS. Thus, these data further implicate a role for the MMPs in progressive renal pathogenesis associated with AS.
Similar articles
-
Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).Kidney Int. 2003 May;63(5):1736-48. doi: 10.1046/j.1523-1755.2003.00939.x. Kidney Int. 2003. PMID: 12675849
-
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.PLoS Med. 2006 Apr;3(4):e100. doi: 10.1371/journal.pmed.0030100. Epub 2006 Mar 7. PLoS Med. 2006. PMID: 16509766 Free PMC article.
-
Abnormal Expression of miR-21 in Kidney Tissue of Dogs With X-Linked Hereditary Nephropathy: A Canine Model of Chronic Kidney Disease.Vet Pathol. 2019 Jan;56(1):93-105. doi: 10.1177/0300985818806050. Epub 2018 Oct 28. Vet Pathol. 2019. PMID: 30370838
-
Biology of metalloproteinases.Rom J Morphol Embryol. 2007;48(4):323-34. Rom J Morphol Embryol. 2007. PMID: 18060181 Review.
-
Matrix metalloproteinases in kidney homeostasis and diseases: an update.Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F967-F984. doi: 10.1152/ajprenal.00179.2024. Epub 2024 Oct 3. Am J Physiol Renal Physiol. 2024. PMID: 39361724 Review.
Cited by
-
Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.Arthritis Res Ther. 2008;10(6):229. doi: 10.1186/ar2532. Epub 2008 Dec 1. Arthritis Res Ther. 2008. PMID: 19090960 Free PMC article. Review.
-
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.Endocrine. 2009 Feb;35(1):1-10. doi: 10.1007/s12020-008-9114-6. Epub 2008 Oct 30. Endocrine. 2009. PMID: 18972226 Free PMC article. Review.
-
Genotype-Based Molecular Mechanisms in Alport Syndrome.J Am Soc Nephrol. 2025 Jun 1;36(6):1176-1183. doi: 10.1681/ASN.0000000647. Epub 2025 Feb 3. J Am Soc Nephrol. 2025. PMID: 39899372 Review.
-
An update on the pathomechanisms and future therapies of Alport syndrome.Pediatr Nephrol. 2013 Jul;28(7):1025-36. doi: 10.1007/s00467-012-2272-z. Epub 2012 Aug 18. Pediatr Nephrol. 2013. PMID: 22903660 Review.
-
Matrix Metalloproteinases-7 and Kidney Fibrosis.Front Physiol. 2017 Feb 10;8:21. doi: 10.3389/fphys.2017.00021. eCollection 2017. Front Physiol. 2017. PMID: 28239354 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous